ANLVSLABT• 12 Months (Normalized)
ANL vs LABT (Adlai Nortye Group Ltd. vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 25, 2025 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANL Performance $15.83
+789.33%
Adlai Nortye Group Ltd.
Normalized Baseline0.00%
LABT Performance $1.78
+%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin ANL LEADS
+789.33 pts
ANL outperforming by 789.33 percentage points
ANLLABT
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANL LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | ANL Price | ANL Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 24, 2026 | $15.83 | +789.33% | $- | - | |
| Sep 23, 2026 | $15.75 | +784.83% | $1.78 | -97.94% | +882.77% |
| Sep 22, 2026 | $16.60 | +832.58% | $1.99 | -97.70% | +930.28% |
| Sep 21, 2026 | $15.57 | +774.72% | $2.05 | -97.63% | +872.35% |
| Sep 18, 2026 | $15.74 | +784.27% | $1.99 | -97.70% | +881.97% |
| Sep 17, 2026 | $15.28 | +758.43% | $1.86 | -97.85% | +856.28% |
| Sep 16, 2026 | $15.52 | +771.91% | $2.09 | -97.58% | +869.49% |
| Sep 15, 2026 | $15.00 | +742.70% | $2.17 | -97.49% | +840.19% |
| Sep 14, 2026 | $15.93 | +794.94% | $2.12 | -97.55% | +892.49% |
| Sep 11, 2026 | $15.21 | +754.49% | $2.22 | -97.43% | +851.92% |
| Sep 10, 2026 | $15.09 | +747.75% | $2.05 | -97.63% | +845.38% |
| Sep 09, 2026 | $14.70 | +725.56% | $2.32 | -97.32% | +822.88% |
| Sep 08, 2026 | $15.51 | +771.35% | $2.18 | -97.48% | +868.83% |
| Sep 04, 2026 | $15.01 | +743.26% | $1.88 | -97.83% | +841.09% |
| Sep 03, 2026 | $14.75 | +728.65% | $1.90 | -97.80% | +826.45% |
Page 1 of 17